NASDAQ:OPRX OptimizeRx Q4 2025 Earnings Report $7.60 -0.02 (-0.26%) Closing price 04:00 PM EasternExtended Trading$7.60 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast OptimizeRx EPS ResultsActual EPS$0.51Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AOptimizeRx Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AOptimizeRx Announcement DetailsQuarterQ4 2025Date1/31/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AUpcoming EarningsOptimizeRx's Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesEarnings HistoryCompany Profile OptimizeRx Earnings HeadlinesOptimizeRx Corp. And The Trade Desk Bring Net New Authenticated HCP Reach To The Trade Desk Through OpenPathSeptember 22 at 12:38 PM | marketscreener.comMOptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPathSeptember 22 at 8:00 AM | globenewswire.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country.September 23 at 1:00 AM | Banyan Hill Publishing (Ad)OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 20 at 4:44 AM | americanbankingnews.comContrasting Waystar (NASDAQ:WAY) & OptimizeRx (NASDAQ:OPRX)September 20 at 3:58 AM | americanbankingnews.comOptimizeRx: Gross Margin Gains And Improved Long-Term OutlookSeptember 18, 2026 | seekingalpha.comSee More OptimizeRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email. Email Address About OptimizeRxOptimizeRx (NASDAQ:OPRX) Corporation (NASDAQ: OPRX) is a digital health company that provides technology and data-driven engagement solutions for life sciences companies, healthcare providers and patients. Its platform is designed to support communication across the healthcare journey, helping pharmaceutical and biotechnology companies connect with clinicians and patients through digital channels. The company’s solutions include point-of-care messaging, patient savings and financial assistance programs, medication adherence and support services, and analytics and audience-engagement tools. OptimizeRx integrates its technology into electronic health records, telehealth platforms and other healthcare workflows to deliver relevant information and resources at the time of care. OptimizeRx primarily serves the U.S. healthcare market and works with pharmaceutical manufacturers, healthcare organizations and technology partners. The company was founded in 2006 and is led by Chief Executive Officer William J. Febbo.View OptimizeRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Energy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?Thor Industries Is Boring—And That May Be Its Biggest AdvantageAutoZone Shifts Gears, On Track to Reverse Course and Price RecoveryMeta’s Muse Highlights Arm’s Growing Role in AI InfrastructureOld Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom Upcoming Earnings Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
